Wegovy (semaglutide) finished product
FDA-approved finished product record
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordEducational status records
What an official status record can—and cannot—show
These pages explain public regulatory classifications using dated official sources. They do not recommend a compound, compare personal suitability, or provide a way to obtain a product.
Education only. A finished approved product, an active ingredient, a compounded
preparation, and a clinical-trial record are different things. The category shown here must not
be transferred from one to another.
Status records
Semaglutide compounded preparation
Compounded; not an FDA-approved finished product
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordRetatrutide clinical-trial record
Investigational study record
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordRetatrutide outside an authorized approval record
Unauthorized pathway warning
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordCosmetic product claim boundary
Cosmetic classification boundary
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordUnspecified peptide product
Status not established in this record
Reviewed 2026-08-18 · review due 2026-09-17
Read educational recordReview rule
Each record has an official source, source-date note, last-reviewed date, and a human review due date. Material status changes require editorial review; the review interval is 30 days.
Report a correction if a source or status record conflicts with current official information.